Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Real-time Estimate Cboe BZX
Other stock markets
 11:45:45 2024-04-29 am EDT 		5-day change 1st Jan Change
5.28 USD -4.00% Intraday chart for Lantern Pharma Inc. -8.04% +22.90%
Apr. 24 Transcript : Lantern Pharma Inc. - Special Call
Apr. 22 Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion MT

Evolution of the average Target Price on Lantern Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

8bd8fef93644f5ab4d1aeb6.ljON6KUGGAWRS_EB9gpVG_bKiqQqf5ajb4XgN8V5knw.pVTZ0Ml-Umv7KoE1mU0Ka52a5pVbOt_aC7OYcrEYyinOVuCBkVBuaMUDpA~1e78bbe3f9ab8ba0df6f917641abab9c

Analyst Recommendations on Lantern Pharma Inc.

HC Wainwright Starts Lantern Pharma at Neutral MT
EF Hutton Starts Lantern Pharma at Buy With $11 Price Target MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $34 From $32, Keeps Buy Rating MT
LANTERN PHARMA : HC Wainwright Starts Lantern Pharma at Buy with $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.5 USD
Average target price
22 USD
Spread / Average Target
+300.00%
High Price Target
26 USD
Spread / Highest target
+372.73%
Low Price Target
18 USD
Spread / Lowest Target
+227.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lantern Pharma Inc.

HC Wainwright
EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. Consensus Lantern Pharma Inc.